Article Information
History
- May 2, 2023.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. This article is a US Government work. It is not subject to copyright under 17 USC 105 and is also made available for use under a CC0 license.
Author Information
- Anson T. Ku†,1,
- Uma Shankavaram†,2,
- Shana Y. Trostel1,
- Hong Zhang2,
- Houssein A. Sater3,
- Stephanie A. Harmon4,
- Nicole V. Carrabba1,
- Yang Liu5,
- Bradford J. Wood6,
- Peter A. Pinto7,
- Peter L. Choyke4,
- Radka Stoyanova8,
- Elai Davicioni5,
- Alan Pollack8,
- Baris Turkbey4,
- Adam G. Sowalsky*,‡,1 and
- Deborah E. Citrin*,‡,2
- 1Laboratory of Genitourinary Cancer Pathogenesis, National Cancer Institute, Bethesda, MD, USA
- 2Radiation Oncology Branch, National Cancer Institute, Bethesda, MD, USA
- 3Genitourinary Malignancies Branch, National Cancer Institute, Bethesda, MD, USA
- 4Molecular Imaging Branch, National Cancer Institute, Bethesda, MD, USA
- 5Veracyte, Inc., South San Francisco, CA, USA
- 6Center for Interventional Oncology, NIH Clinical Center, Bethesda, MD, USA
- 7Urologic Oncology Branch, National Cancer Institute, Bethesda, MD, USA
- 8Department of Radiation Oncology, University of Miami, Miami, FL, USA
- ↵*To whom correspondence may be addressed: Adam G. Sowalsky, National Cancer Institute, 37 Convent Drive, Bethesda, MD 20892 USA, adam.sowalsky{at}nih.gov, (240) 760-7118 -or- Deborah E. Citrin, National Cancer Institute, 10 Center Drive, Bethesda, MD 20892 USA, deborah.citrin{at}nih.gov, (301) 496-5457